LONDON – Synendos Therapeutics AG is poised for a fresh attempt at drugging the endogenous endocannabinoid system after raising CHF20 million (US$21.8 million) to take its lead program into clinical development.
TORONTO – Biomaterials med-tech company 3D Biofibr Inc. has raised CA$550,000 (US$423,500) seed funding to develop, commercialize and scale up a biofilm platform that mimics the spinning behavior of the common spider.
Though founded in 2018, Inipharm Inc. has just closed on a $35 million series A financing designed to push its lead program through an IND filing and into the clinic to treat liver-related diseases.
Varian Medical Systems Inc. has invested $10 million in and inked a collaboration agreement with Cota Inc., a Boston-based curator of oncology clinical data. The radiation oncology company will now offer its customers access to Cota’s oncology real-world analytics and data curation services, which aggregate electronic health record (EHR) data to yield meaningful insights.
Biopharmas in Asia-Pacific raising money in public or private financings, including: Fountain Healthcare Partners, Inmagene, Inotrem, Kyowa Kirin, Mainstay Medical Holdings, Memo, Patrys, Priothera, Vaxil Bio.
RSS
